Paraoxonase-1 gene Leu-Met55 and Gln-Arg192 polymorphisms are not associated with carotid artery atherosclerosis in a population-based cohort

Eur J Cardiovasc Prev Rehabil. 2004 Dec;11(6):511-2. doi: 10.1097/01.hjr.0000136415.17146.38.

Abstract

Background: Paraoxonase-1 (PON1) is an enzyme that prevents low-density lipoprotein (LDL) oxidation. The role of polymorphisms of PON1 determining early atherosclerotic changes is currently unclear.

Design: Cross sectional cohort study.

Methods: Nine hundred and ninety-nine subjects from a population-based cohort were screened. Intima-media thickness (IMT) was measured by ultrasonography. Leu-Met55 and Gln-Arg192 polymorphism were determined.

Results: No association between PON1 genotypes and IMT was found. This finding remained after adjusting for confounding factors.

Conclusions: The PON1 Leu-Met55 and Gln-Arg192 polymorphisms are not major risk factors for atherosclerosis in the general Caucasian population.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arginine / genetics
  • Arteriosclerosis / genetics*
  • Arteriosclerosis / pathology
  • Aryldialkylphosphatase / genetics*
  • Carotid Artery, Common / pathology*
  • Case-Control Studies
  • Cohort Studies
  • Cross-Sectional Studies
  • Dipeptides / genetics
  • Finland
  • Gene Frequency
  • Genotype
  • Glutamine / genetics
  • Humans
  • Hypertension / epidemiology
  • Polymerase Chain Reaction
  • Polymorphism, Restriction Fragment Length*
  • Registries
  • Tunica Intima / pathology
  • Tunica Media / pathology
  • White People / genetics

Substances

  • Dipeptides
  • Glutamine
  • leucylmethionine
  • Arginine
  • Aryldialkylphosphatase